Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.07.2020 | Case report

Anlotinib/icotinib/pembrolizumab

Pancreatitis, thyroiditis and myocarditis and acquired resistance: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zhang C, et al. Significance of genetic sequencing in patients with lung adenocarcinoma with transformation to small cell lung cancer: A case report and systematic review. Translational Cancer Research 9: 3725-3733, No. 5, May 2020. Available from: URL: http://doi.org/10.21037/tcr-19-2291 Zhang C, et al. Significance of genetic sequencing in patients with lung adenocarcinoma with transformation to small cell lung cancer: A case report and systematic review. Translational Cancer Research 9: 3725-3733, No. 5, May 2020. Available from: URL: http://​doi.​org/​10.​21037/​tcr-19-2291
Metadaten
Titel
Anlotinib/icotinib/pembrolizumab
Pancreatitis, thyroiditis and myocarditis and acquired resistance: case report
Publikationsdatum
01.07.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-80253-z

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Clozapine